A study based on partial deletion of hepatic IR in mice fed a HFD observed an amelioration of hepatic steatosis (Merry et al., 2020); therefore, the decrease observed in our HFD-fed Apoe−/− mice could serve as an attempt to avoid NAFLD progression. This evidence concerns the gene APOE and metabolic dysfunction-associated steatotic liver disease.